Securities code: 688575 securities abbreviation: Shenzhen Yhlo Biotech Co.Ltd(688575) Announcement No.: 2021-030
Shenzhen Yhlo Biotech Co.Ltd(688575)
Announcement on voluntary disclosure of medical device registration certificate obtained by holding subsidiary
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Recently, Hunan Zhuoren Biotechnology Co., Ltd., a holding subsidiary of Shenzhen Yhlo Biotech Co.Ltd(688575) (hereinafter referred to as “the company”), received the medical device registration certificate issued by Hunan drug administration. The specific information is as follows:
1、 Basic information of medical device registration certificate
Product name registration number registration certificate validity registration classification intended use
number
1 chitosanase 3-like protein 1 was tested and approved by Xiangxi injection to December 20, 2026. Ⅱ was used to qualitatively detect chitosanase 3-like protein 1 in human fingertip test kit (colloidal gold method) 20212402287 blood in vitro.
2、 Impact on the company
Chitosanase 3-like protein 1 test kit obtained this time (colloidal gold method) chitosanase 3-like protein 1 can be detected by professionals, diseased non professionals skilled in the operation or their families at home or in medical units. Chitosanase 3-like protein 1 is a biomarker of alcoholic liver cirrhosis, hepatitis C virus and hepatitis B virus induced liver cirrhosis. This certification further enriches the company’s POCT products Types, enhance the competitiveness of the company in the household medical device market, and better meet the diversified needs of the market.
3、 Risk tips
The acquisition of this registration certificate only represents that the relevant products of the company have obtained the Chinese market access qualification. However, the actual sales of the above products depend on the future marketing effect, and the company is unable to predict its impact on the company’s future performance. Please invest rationally and pay attention to investment risks.
It is hereby announced.
Shenzhen Yhlo Biotech Co.Ltd(688575) board of directors December 24, 2021
